| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
C - A |
50,000 |
0.00 |
0.00 |
50,000 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
2,188 |
103.61 |
226,701.09 |
47,812 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
10,690 |
104.60 |
1,118,175.07 |
37,122 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
21,927 |
105.49 |
2,312,998.10 |
15,195 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
5,511 |
106.25 |
585,559.18 |
9,684 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
1,395 |
107.32 |
149,714.19 |
8,289 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
2,974 |
108.43 |
322,478.85 |
5,315 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
2,304 |
109.35 |
251,938.02 |
3,011 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
1,031 |
110.53 |
113,957.46 |
1,980 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
949 |
111.36 |
105,676.56 |
1,031 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
303 |
112.52 |
34,093.47 |
728 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
S - D |
728 |
113.87 |
82,899.03 |
0 |
| CRWV |
CoreWeave, Inc. |
Intrator Michael N |
Director
Officer
10% Owner
|
2026-01-28 |
C - D |
50,000 |
0.00 |
0.00 |
25,049,280 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
30,000 |
15.00 |
450,000.00 |
30,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
9.70 |
145,500.00 |
45,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
12.50 |
187,500.00 |
60,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
3.61 |
54,150.00 |
75,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
2.00 |
30,000.00 |
90,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
3.27 |
49,050.00 |
105,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
2.74 |
41,100.00 |
120,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
2.60 |
39,000.00 |
135,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
0.99 |
14,848.50 |
150,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
0.96 |
14,475.00 |
165,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
2.49 |
37,350.00 |
180,000 |
| CRVS |
Corvus Pharmaceuticals, Inc. |
Thompson Peter A. |
Director
10% Owner
|
2026-01-28 |
M - A |
15,000 |
1.64 |
24,600.00 |
195,000 |